19-4343845-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001300862.2(MPND):āc.145G>Cā(p.Val49Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000462 in 1,211,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001300862.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPND | NM_001300862.2 | c.145G>C | p.Val49Leu | missense_variant | 2/13 | ENST00000599840.6 | NP_001287791.1 | |
MPND | NM_032868.6 | c.145G>C | p.Val49Leu | missense_variant | 2/12 | NP_116257.2 | ||
MPND | NM_001159846.3 | c.145G>C | p.Val49Leu | missense_variant | 2/11 | NP_001153318.1 | ||
MPND | XM_006722926.3 | c.145G>C | p.Val49Leu | missense_variant | 2/13 | XP_006722989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPND | ENST00000599840.6 | c.145G>C | p.Val49Leu | missense_variant | 2/13 | 5 | NM_001300862.2 | ENSP00000471735.1 |
Frequencies
GnomAD3 genomes AF: 0.0000930 AC: 14AN: 150488Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000396 AC: 42AN: 1061508Hom.: 0 Cov.: 30 AF XY: 0.0000415 AC XY: 21AN XY: 505452
GnomAD4 genome AF: 0.0000930 AC: 14AN: 150488Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 73472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2023 | The c.145G>C (p.V49L) alteration is located in exon 2 (coding exon 2) of the MPND gene. This alteration results from a G to C substitution at nucleotide position 145, causing the valine (V) at amino acid position 49 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at